1 – 10 of 1772
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B : a PedNet study
- Achieving the unimaginable : Health equity in haemophilia
- Second malignancies in multiple myeloma; emerging patterns and future directions
- Progression of progenitor B-cell leukemia is associated with alterations of the bone marrow micro-environment
- The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting
-
Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A : Interim analysis from the LEOPOLD Kids extension study
Kenet, Gili ; Ljung, Rolf LU
;
Rusen, Luminita
;
Kerlin, Bryce A
;
Blanchette, Victor
;
Saulytė Trakymienė, Sonata
;
Uscatescu, Valentina
;
Beckmann, Horst
;
Tseneklidou-Stoeter, Despina
and
Church, Nikki
(2020)
In Thrombosis Research
189.
p.96-101
Mark
- European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
-
Characterization of GYP*Mur and novel GYP*Bun-like hybrids in Thai blood donors reveals a qualitatively altered s antigen
Jongruamklang, Philaiphon LU ; Grimsley, Shane ; Thornton, Nicole ; Robb, Janine ; Olsson, Martin L. LU
and
Storry, Jill R.
LU
(2020)
In Vox Sanguinis
Mark
- Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy
- Decreasing early mortality in acute myeloid leukaemia in Sweden 1997–2014 : improving performance status is a major contributing factor